Brett A. Wall - 08 Jan 2025 Form 4 Insider Report for Medtronic plc (MDT)

Signature
/s/ Thomas L. Osteraas, attorney-in-fact
Issuer symbol
MDT
Transactions as of
08 Jan 2025
Net transactions value
-$279,384
Form type
4
Filing time
10 Jan 2025, 16:48:57 UTC
Previous filing
17 Dec 2024
Next filing
27 Jan 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDT Ordinary Shares Options Exercise $512,654 +6,850 +16% $74.84 50,558 08 Jan 2025 Direct
transaction MDT Ordinary Shares Sale $550,808 -6,850 -14% $80.41 43,708 08 Jan 2025 Direct
transaction MDT Ordinary Shares Sale $241,230 -3,000 -6.9% $80.41 40,708 08 Jan 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDT Stock Option (Right to Buy) Options Exercise $0 -6,850 -100% $0.000000 0 08 Jan 2025 Ordinary Shares 6,850 $74.84 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Remarks:

The transactions dated January 8, 2025 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on October 10, 2024.